drugset / Trial / NCT00961090
Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery
NaSingle-groupOpen-labelTreatment
Summary
A one time oral dose of ALA is taken before surgery. The medication makes the tumor visible under ultraviolet light which allow the surgeon to see more of the tumor for a more complete removal.
Timeline
- Start
- 2009-09
- Primary completion
- 2015-04-22
- Completion
- 2015-04-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aminolevulinic Acid | Diagnostic / imaging agent | 20 mg/kg | Oral |